| Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial R Stupp, S Taillibert, A Kanner, W Read, DM Steinberg, B Lhermitte, ... Jama 318 (23), 2306-2316, 2017 | 2362 | 2017 |
| Chemotherapy-induced peripheral neurotoxicity (CIPN): an update AA Argyriou, J Bruna, P Marmiroli, G Cavaletti Critical reviews in oncology/hematology 82 (1), 51-77, 2012 | 673 | 2012 |
| The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings G Cavaletti, DR Cornblath, ISJ Merkies, TJ Postma, E Rossi, B Frigeni, ... Annals of Oncology 24 (2), 454-462, 2013 | 359 | 2013 |
| Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer AA Argyriou, G Cavaletti, C Briani, R Velasco, J Bruna, M Campagnolo, ... Cancer 119 (2), 438-444, 2013 | 268 | 2013 |
| Neuronal surface antigen antibodies in limbic encephalitis: clinical–immunologic associations F Graus, A Saiz, M Lai, J Bruna, F López, L Sabater, Y Blanco, MJ Rey, ... Neurology 71 (12), 930-936, 2008 | 263 | 2008 |
| Rapid eye movement sleep behavior disorder and potassium channel antibody–associated limbic encephalitis A Iranzo, F Graus, L Clover, J Morera, J Bruna, C Vilar, ... Annals of neurology 59 (1), 178-181, 2006 | 249 | 2006 |
| Chemobrain: a systematic review of structural and functional neuroimaging studies M Simó, X Rifà-Ros, A Rodriguez-Fornells, J Bruna Neuroscience & Biobehavioral Reviews 37 (8), 1311-1321, 2013 | 237 | 2013 |
| Ki‐67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma J Bruna, M Brell, I Ferrer, P Gimenez‐Bonafe, A Tortosa Neuropathology 27 (2), 114-120, 2007 | 212 | 2007 |
| Influence of treatment with tumor-treating fields on health-related quality of life of patients with newly diagnosed glioblastoma: a secondary analysis of a randomized clinical … MJB Taphoorn, L Dirven, AA Kanner, G Lavy-Shahaf, U Weinberg, ... JAMA oncology 4 (4), 495-504, 2018 | 193 | 2018 |
| Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin P Alberti, E Rossi, DR Cornblath, ISJ Merkies, TJ Postma, B Frigeni, ... Annals of oncology 25 (1), 257-264, 2014 | 188 | 2014 |
| Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients R Velasco, J Bruna, C Briani, AA Argyriou, G Cavaletti, P Alberti, B Frigeni, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (4), 392-398, 2014 | 174 | 2014 |
| Syndrome and outcome of antibody‐negative limbic encephalitis F Graus, D Escudero, L Oleaga, J Bruna, A Villarejo‐Galende, ... European Journal of Neurology 25 (8), 1011-1016, 2018 | 138 | 2018 |
| Voltage‐gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin‐induced peripheral neurotoxicity: Results from a prospective multicenter study AA Argyriou, G Cavaletti, A Antonacopoulou, AA Genazzani, C Briani, ... Cancer 119 (19), 3570-3577, 2013 | 136 | 2013 |
| Anti-Hu-associated brainstem encephalitis A Saiz, J Bruna, P Stourac, MC Vigliani, B Giometto, W Grisold, ... Journal of Neurology, Neurosurgery & Psychiatry 80 (4), 404-407, 2009 | 127 | 2009 |
| Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients AA Argyriou, R Velasco, C Briani, G Cavaletti, J Bruna, P Alberti, ... Annals of oncology 23 (12), 3116-3122, 2012 | 125 | 2012 |
| Efficacy of a novel sigma-1 receptor antagonist for oxaliplatin-induced neuropathy: a randomized, double-blind, placebo-controlled phase IIa clinical trial J Bruna, S Videla, AA Argyriou, R Velasco, J Villoria, C Santos, C Nadal, ... Neurotherapeutics 15 (1), 178-189, 2018 | 120 | 2018 |
| Taxane-induced peripheral neurotoxicity R Velasco, J Bruna Toxics 3 (2), 152-169, 2015 | 120 | 2015 |
| Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice J Bruna, E Udina, A Alé, JJ Vilches, A Vynckier, J Monbaliu, L Silverman, ... Experimental neurology 223 (2), 599-608, 2010 | 120 | 2010 |
| Chemotherapy-induced peripheral neuropathy: an unresolved issue R Velasco, J Bruna Neurología (English Edition) 25 (2), 116-131, 2010 | 118 | 2010 |
| Cognitive and brain structural changes in a lung cancer population M Simó, JC Root, L Vaquero, P Ripollés, J Jové, T Ahles, A Navarro, ... Journal of Thoracic Oncology 10 (1), 38-45, 2015 | 116 | 2015 |
Paola Alberti, MD, PhD, Board in Neur...School of Medicine and Surgery, University of Milano-BicoccaVerified email at unimib.it
